# Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog

> **NCT02767596** · PHASE4 · TERMINATED · sponsor: **Laniado Hospital** · enrollment: 2 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** Lixisenatide
- **DRUG:** Basal insulins

## Key facts

- **NCT ID:** NCT02767596
- **Lead sponsor:** Laniado Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-07-12
- **Primary completion:** 2017-02
- **Final completion:** 2017-02-21
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Insufficient recruitment rate
- **Last updated:** 2017-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02767596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02767596, "Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02767596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*